Cutting Edge Cancer Treatments
Dear OncoLink "Ask the Experts,"
I am currently being treated with oxaliplatin for metastatic colon cancer in the liver. Where do you think the most promising future colon cancer help will come from angiogenesis inhibitors, monoclonal antibodies, or vaccines?
James P. Stevenson, MD, Assistant Professor of Medicine in the Hematology/Oncology Division of the University of Pennsylvania School of Medicine, responds:
All of those agents (angiogenesis inhibitors, monoclonal antibodies, and vaccines) hold promise for colorectal cancer. At this point, no one agent seems to stand out. Examples of each that are being studied in colon cancer include;
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2016 Trustees of The University of Pennsylvania